Integra LifeSciences (IART) Stock: Buy, Sell, or Hold?
IART - Integra LifeSciences Holdings
$15.53
-0.01 (-0.06%)
▼
5d:
-5.54%
30d:
-10.64%
90d:
-11.31%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Oct 29, 2026
Get Alerted When IART Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: IART shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: IART shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$18.40
Based on 5.1% avg growth
INTRINSIC VALUE TODAY
$11.42
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 5.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IART is currently trading at $15.53, which is considered oversold relative to its 30-day fair value range of $16.44 to $17.68. The stock's valuation (Forward PE: 6.0) is in line with its historical norms (5.5). At these levels, the market is pricing in 2.9% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, IART is in a uptrend. The price is currently testing key support at $15.33. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: IART scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $19.56 (+25.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IART is in a uptrend. The price is currently testing key support at $15.33. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: IART scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $19.56 (+25.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$16.44 -
$17.68
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
Protect Your Profits
Holding IART? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 25.8% below Wall St target ($19.56)
- BEARISH: Market expects 2.9% growth - appears too optimistic based on history
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$16.44 -
$17.68
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$15.33
Resistance Level
$17.33
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
5.96
Wall Street Target
$19.56
(+25.8%)
Revenue Growth (YoY)
0.8%
Earnings Growth (YoY)
0.4%
Profit Margin
-0.4%
Valuation Premium vs History
+2.9% premium
PE vs Historical
6.0 vs 5.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.9%
(market-implied from PE analysis)
1-Year Target
$15.99
(+3%)
2-Year Target
$16.45
(+6%)
3-Year Target
$16.93
(+9%)
3-Yr Target (if PE normalizes)
(PE: 6→6)
PE COMPRESSION
$15.63
(+1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 6.2%)
$62.96
(+305%)
Base:
(SPY PE: 6.0, Growth: 6.2%)
$18.60
(+20%)
Bear:
(PE: 5.1, Growth: 6.2%)
$15.81
(+2%)
Share & Embed Analysis
Last updated: September 11, 2026 2:52 PM ET
Data refreshes hourly during market hours. Next update: 3:52 PM
Data refreshes hourly during market hours. Next update: 3:52 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IART showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 40 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 44 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 56 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 41 HOLD |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$108 | 50 HOLD |
Advanced IART Option Strategies
Professional options setups generated by AI based on today's IART price and gamma walls.
